Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF-Reference-Cited by-同舟云学术

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF

Published:2005-01 Issue:1 Volume:149 Page:159-167
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Deedwania Prakash C.,Giles Thomas D.,Klibaner Michael,Ghali Jalal K.,Herlitz Johan,Hildebrandt Per,Kjekshus John,Spinar Jindrich,Vitovec Jiri,Stanbrook Hilary,Wikstrand John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial;Lancet,1999

2. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure. (MERIT-HF);Lancet,1999

3. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure;Hjalmarson;JAMA,2000

4. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001

5. Results from post-hoc analyses of the CIBIS II trial;Erdmann;Eur J Heart Fail,2001

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herzinsuffizienz bei Patienten mit Diabetes mellitus;Aktuelle Kardiologie;2024-07-31

2. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy;Frontiers in Endocrinology;2024-07-30

3. Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA‐HF and DELIVER;European Journal of Heart Failure;2024-07-17

4. Safety and tolerability of β-blockers: importance of cardioselectivity;Current Medical Research and Opinion;2024-04

5. Rethinking the Impact and Management of Diabetes in Heart Failure Patients;Current Heart Failure Reports;2023-12-04